高级检索
当前位置: 首页 > 详情页

Microwave ablation versus partial nephrectomy for small renal tumors: Intermediate-term results

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol,Tongji Med Coll,Dept Urol,Tongji Hosp,Wuhan 430030,Peoples R China
出处:
ISSN:

关键词: kidney neoplasms microwaves catheter ablation nephrectomy treatment outcome

摘要:
Background and Objectives Prospective randomized comparison of intermediate-term outcomes of patients with small renal tumors who were treated with partial nephrectomy (PN) or microwave ablation. Methods Of 102 selected patients with solitary small renal tumors who had prospectively completed at least 2 years of follow-up since December 2004, randomizedly, 54 had either open (19) or laparoscopic (35) PN and 48 had laparoscopic (28) or open (20) microwave ablation. Patient and tumor characteristics, surgical data, complications, histologic and oncologic data, and functional data of the two approaches were compared. Results Patients in microwave ablation group and PN group matched for age, sex, American Society of Anesthesiologists score, body mass index, and tumor size and were respectively followed for median 32 and 36 months. Surgical and hospitalization times were comparable in both groups. Estimated blood loss, complication rates, and decline of postoperative renal function were significantly less in the microwave ablation group (P?=?0.0002, P?=?0.0187, and P?=?0.0092, respectively). The decrease in estimated glomerular filtration rate at the last available follow-up was similar in both groups (P?=?1.0000). There were no disease-specific deaths. KaplanMeier estimates of overall local recurrence-free survival at 3 years were 91.3% for microwave ablation and 96.0% for PN (P?=?0.5414); the respective numbers for renal cell carcinomas were 90.4 and 96.6% (P?=?0.4650). Conclusions Microwave ablation can be also safely and efficiently done for patients with small renal tumors. This intermediate analysis showed that microwave ablation provides favorable results compared to PN. However, longer term data are still needed. J. Surg. Oncol. 2012; 106:316-321. (c) 2012 Wiley Periodicals, Inc.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2011]版:
大类 | 3 区 医学
小类 | 3 区 外科 4 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学 4 区 外科
JCR分区:
出版当年[2010]版:
Q1 SURGERY Q3 ONCOLOGY
最新[2023]版:
Q2 SURGERY Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2010版] 出版当年五年平均 出版前一年[2009版] 出版后一年[2011版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol,Tongji Med Coll,Dept Urol,Tongji Hosp,Wuhan 430030,Peoples R China
通讯作者:
通讯机构: [1]Huazhong Univ Sci & Technol,Tongji Med Coll,Dept Urol,Tongji Hosp,Wuhan 430030,Peoples R China [*1]Huazhong Univ Sci & Technol,Tongji Med Coll,Dept Urol,Tongji Hosp,1095 Jiefang Ave,Wuhan 430030,Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:0 总访问量:410 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)